Filter
Period
Filter by
recent search
Showing: 1 – 05 of 153 Regulated Information
IPSEN: Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
Ipsen presents strong full-year 2022 results and guidance for 2023
Paris (France), 9 February 2023
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
PARIS, FRANCE & BOSTON, U.S., 09 January 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) and Albireo (Nasdaq: ALBO) today announced that they have entered into a definitive merger agreement under which Ipsen will acquire Albireo, a leading innovator in bile-acid modulators…
Ipsen – Half year statement – 2022 12 31
This article or press release has no online content. Please download the associated documents for more information.
Voting rights on 31 December 2022
This article or press release has no online content. Please download the associated documents for more information.